{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:10:58Z","timestamp":1780438258571,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81730003"],"award-info":[{"award-number":["81730003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870120"],"award-info":[{"award-number":["81870120"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20171205"],"award-info":[{"award-number":["BK20171205"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Social Development Project of Jiangsu Province","award":["BE2019655"],"award-info":[{"award-number":["BE2019655"]}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","award":["PAPD"],"award-info":[{"award-number":["PAPD"]}],"id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"crossref","award":["2017ZX09304021"],"award-info":[{"award-number":["2017ZX09304021"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"crossref","award":["2017YFA0104500"],"award-info":[{"award-number":["2017YFA0104500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"crossref","award":["2019YFC0840604"],"award-info":[{"award-number":["2019YFC0840604"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s12185-021-03081-2","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T20:02:57Z","timestamp":1611864177000},"page":"682-692","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Characteristics and transplant outcome of myeloid sarcoma: a single-institute study"],"prefix":"10.1007","volume":"113","author":[{"given":"Meng","family":"Shan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenqi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Depei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"key":"3081_CR1","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391\u2013405.","journal-title":"Blood"},{"key":"3081_CR2","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1182\/blood-2011-04-347229","volume":"118","author":"RL Bakst","year":"2011","unstructured":"Bakst RL, Tallman MS, Douer D, Yahalom J. How I treat extramedullary acute myeloid leukemia. Blood. 2011;118:3785\u201393.","journal-title":"Blood"},{"key":"3081_CR3","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1200\/JCO.1997.15.2.466","volume":"15","author":"JC Byrd","year":"1997","unstructured":"Byrd JC, Weiss RB, Arthur DC, Lawrence D, Baer MR, Davey F, et al. Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461. J Clin Oncol. 1997;15:466\u201375.","journal-title":"J Clin Oncol"},{"key":"3081_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","volume":"115","author":"H D\u00f6hner","year":"2010","unstructured":"D\u00f6hner H, Estey EH, Amadori S, Appelbaum FR, B\u00fcchner T, Burnett AK, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115:453\u201374.","journal-title":"Blood"},{"key":"3081_CR5","first-page":"663","volume":"18","author":"O Huter","year":"1996","unstructured":"Huter O, Brezinka C, Nachbaur D, Schwaighofer H, Lang A, Niederwieser D. Successful treatment of primary extramedullary leukemia (EML) of the uterus with radical surgery, chemotherapy, autologous bone marrow transplantation (BMT) and prophylactic local irradiation. Bone Marrow Transplant. 1996;18:663\u20134.","journal-title":"Bone Marrow Transplant"},{"key":"3081_CR6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/sj.leu.2404491","volume":"21","author":"SA Pileri","year":"2007","unstructured":"Pileri SA, Ascani S, Cox MC, Campidelli C, Bacci F, Piccioli M, et al. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia. 2007;21:340\u201350.","journal-title":"Leukemia"},{"key":"3081_CR7","doi-asserted-by":"publisher","first-page":"4940","DOI":"10.1200\/JCO.2007.15.6315","volume":"26","author":"P Chevallier","year":"2008","unstructured":"Chevallier P, Mohty M, Lioure B, Michel G, Contentin N, Deconinck E, et al. Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC. J Clin Oncol. 2008;26:4940\u20133.","journal-title":"J Clin Oncol"},{"key":"3081_CR8","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.3324\/haematol.2011.041418","volume":"96","author":"P Chevallier","year":"2011","unstructured":"Chevallier P, Labopin M, Cornelissen J, Soci\u00e9 G, Rocha V, Mohty M, et al. Allogeneic hematopoietic stem cell transplantation for isolated and leukemic myeloid sarcoma in adults: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation. Haematologica. 2011;96:1391\u20134.","journal-title":"Haematologica"},{"key":"3081_CR9","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1038\/leu.2012.156","volume":"26","author":"H Shimizu","year":"2012","unstructured":"Shimizu H, Saitoh T, Tanaka M, Mori T, Sakura T, Kawai N, et al. Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcoma. Leukemia. 2012;26:2469\u201373.","journal-title":"Leukemia"},{"key":"3081_CR10","doi-asserted-by":"crossref","unstructured":"Lazzarotto D, Candoni A, Fil\u00ec C, Forghieri F, Pagano L, Busca A, et al. (2017) Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey. Leuk Res 53: 74\u201381.","DOI":"10.1016\/j.leukres.2016.12.003"},{"key":"3081_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/ejh.12909","volume":"99","author":"C Bourlon","year":"2017","unstructured":"Bourlon C, Lipton JH, Deotare U, Gupta V, Kim DD, Kuruvilla J, et al. Extramedullary disease at diagnosis of AML does not influence outcome of patients undergoing allogeneic hematopoietic cell transplant in CR1. Eur J Haematol. 2017;99:234\u20139.","journal-title":"Eur J Haematol"},{"key":"3081_CR12","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H D\u00f6hner","year":"2017","unstructured":"D\u00f6hner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, B\u00fcchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424\u201347.","journal-title":"Blood"},{"key":"3081_CR13","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/sj.leu.2402958","volume":"17","author":"AM Tsimberidou","year":"2003","unstructured":"Tsimberidou AM, Kantarjian HM, Estey E, Cortes JE, Verstovsek S, Faderl S, et al. Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy. Leukemia. 2003;17:1100\u20133.","journal-title":"Leukemia"},{"key":"3081_CR14","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1177\/096368979800700401","volume":"7","author":"MY Gordon","year":"1998","unstructured":"Gordon MY, Blackett NM. Reconstruction of the hematopoietic system after stem cell transplantation. Cell Transplant. 1998;7:339\u201344.","journal-title":"Cell Transplant"},{"key":"3081_CR15","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/s41409-018-0204-7","volume":"53","author":"HM Schoemans","year":"2018","unstructured":"Schoemans HM, Lee SJ, Ferrara JL, Wolff D, Levine JE, Schultz KR, et al. EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment. Bone Marrow Transplant. 2018;53:1401\u201315.","journal-title":"Bone Marrow Transplant"},{"key":"3081_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/sim.4780030106","volume":"3","author":"R Simon","year":"1984","unstructured":"Simon R, Makuch RW. A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias. Stat Med. 1984;3:35\u201344.","journal-title":"Stat Med"},{"key":"3081_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/01621459.1974.10480131","volume":"69","author":"N Mantel","year":"1974","unstructured":"Mantel N, Byar DP. Evaluation of response-time data involving transient States: an illustration using heart-transplant data. Public Am Stat Assoc. 1974;69:81\u20136.","journal-title":"Public Am Stat Assoc"},{"key":"3081_CR18","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1002\/cncr.23691","volume":"113","author":"AM Tsimberidou","year":"2008","unstructured":"Tsimberidou AM, Kantarjian HM, Wen S, Keating MJ, O\u2019Brien S, Brandt M, et al. Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia. Cancer. 2008;113:1370\u20138.","journal-title":"Cancer"},{"key":"3081_CR19","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1002\/cncr.10399","volume":"94","author":"K Yamauchi","year":"2002","unstructured":"Yamauchi K, Yasuda M. Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature. Cancer. 2002;94:1739\u201346.","journal-title":"Cancer"},{"key":"3081_CR20","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1111\/j.1349-7006.2012.02324.x","volume":"103","author":"H Shimizu","year":"2012","unstructured":"Shimizu H, Saitoh T, Hatsumi N, Takada S, Yokohama A, Handa H, et al. Clinical significance of granulocytic sarcoma in adult patients with acute myeloid leukemia. Cancer Sci. 2012;103:1513\u20137.","journal-title":"Cancer Sci"},{"key":"3081_CR21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00432-020-03128-7","volume":"146","author":"LH Xu","year":"2020","unstructured":"Xu LH, Wang Y, Chen ZY, Fang JP. Myeloid sarcoma is associated with poor clinical outcome in pediatric patients with acute myeloid leukemia. J Cancer Res Clin Oncol. 2020;146:1011\u201320.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3081_CR22","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1182\/blood-2006-02-003327","volume":"108","author":"MA Vodyanik","year":"2006","unstructured":"Vodyanik MA, Thomson JA, Slukvin II. Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood. 2006;108:2095\u2013105.","journal-title":"Blood"},{"key":"3081_CR23","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/ajh.21406","volume":"84","author":"A Broyde","year":"2009","unstructured":"Broyde A, Boycov O, Strenov Y, Okon E, Shpilberg O, Bairey O. Role and prognostic significance of the Ki-67 index in non-Hodgkin\u2019s lymphoma. Am J Hematol. 2009;84:338\u201343.","journal-title":"Am J Hematol"},{"key":"3081_CR24","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1200\/JCO.1993.11.4.690","volume":"11","author":"MS Tallman","year":"1993","unstructured":"Tallman MS, Hakimian D, Shaw JM, Lissner GS, Russell EJ, Variakojis D. Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia. J Clin Oncol. 1993;11:690\u20137.","journal-title":"J Clin Oncol"},{"key":"3081_CR25","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0145-2126(01)00068-6","volume":"25","author":"E Psiachou-Leonard","year":"2001","unstructured":"Psiachou-Leonard E, Paterakis G, Stefanaki K, Mikraki-Christou V, Haidas S. Cerebellar granulocytic sarcoma in an infant with CD56+ acute monoblastic leukemia. Leuk Res. 2001;25:1019\u201321.","journal-title":"Leuk Res"},{"key":"3081_CR26","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1038\/sj.leu.2404699","volume":"21","author":"B Falini","year":"2007","unstructured":"Falini B, Lenze D, Hasserjian R, Coupland S, Jaehne D, Soupir C, et al. Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. Leukemia. 2007;21:1566\u201370.","journal-title":"Leukemia"},{"key":"3081_CR27","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/j.1365-2141.2004.05124.x","volume":"126","author":"MA Ansari-Lari","year":"2004","unstructured":"Ansari-Lari MA, Yang CF, Tinawi-Aljundi R, Cooper L, Long P, Allan RH, et al. FLT3 mutations in myeloid sarcoma. Br J Haematol. 2004;126:785\u201391.","journal-title":"Br J Haematol"},{"issue":"9","key":"3081_CR28","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1038\/s41375-018-0056-6","volume":"32","author":"C Willekens","year":"2018","unstructured":"Willekens C, Renneville A, Broutin S, Saada V, Micol JB, Delahousse J, et al. Mutational profiling of isolated myeloid sarcomas and utility of serum 2HG as biomarker of IDH1\/2 mutations. Leukemia. 2018;32(9):2008\u201381.","journal-title":"Leukemia"},{"key":"3081_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/10428194.2017.1339879","volume":"59","author":"K Kashofer","year":"2018","unstructured":"Kashofer K, Gornicec M, Lind K, Caraffini V, Schauer S, Beham-Schmid C, et al. Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencing. Leuk Lymphoma. 2018;59:501\u20134.","journal-title":"Leuk Lymphoma"},{"key":"3081_CR30","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1182\/blood-2017-07-793620","volume":"131","author":"V Lazarevic","year":"2018","unstructured":"Lazarevic V, Orsmark-Pietras C, Lilljebj\u00f6rn H, Pettersson L, Rissler M, L\u00fcbking A, et al. Isolated myelosarcoma is characterized by recurrent NFE2 mutations and concurrent preleukemic clones in the bone marrow. Blood. 2018;131:577\u201381.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-021-03081-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-021-03081-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-021-03081-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T22:19:35Z","timestamp":1620253175000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-021-03081-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["3081"],"URL":"https:\/\/doi.org\/10.1007\/s12185-021-03081-2","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,28]]},"assertion":[{"value":"3 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}